To homepage
4.6/5
TrustPilot

Best Vaccination Doctors in Turkey for Australians

Compare top Vaccination doctors and prices in Turkey. Find your best match here.

Get quotes from 3 top Vaccination specialists in Turkey

We'll hand-pick the best doctors based on your needs and budget.

Meet the experts behind this page

Top doctors

11

Turkey

Reviews

14,000+

From real patients

Choose the country with the best prices for doctors' services

Compare prices for Vaccination across top countries

Tap a country to view top doctors and prices

France
Turkey
Thailand
Czech Republic
Austria
Spain
AUD $0 - AUD $142
AUD $0 - AUD $284
AUD $0 - AUD $142
AUD $0 - AUD $142
AUD $0 - AUD $142
AUD $0 - AUD $142
AUD $0
AUD $1,420

What Bookimed patients actually pay for Vaccination in Turkey

Most popular range

$100

$200

$300

$500

$700

AUD $0 – AUD $284

Most patients pay within this range

The exact cost depends on the chosen doctor, technique, areas treated, and your individual needs.

Get a precise quote for your case.

Get free personalised treatment plans and choose the best option. No commitment · No payments for our services

Show first:

Kursad Aydin

  • 3 Good 8 reviews
  • 28 years of experience
  • Location: Turkey, Istanbul
  • Dr. has worked in various medical institutions from 1998-2017, including Gazi University (2001-2003) and Selcuk University (1998-2001, 2003-2009, 2009-2010).

  • Read more
Doctor's visit
Price on request

Onder Yavascan

  • 5 Excellent 2 reviews
  • 25 years of experience
  • Location: Turkey, Istanbul
  • The doctor is a Pediatric Nephrologist at Medipol Mega University Hospital with extensive experience in pediatric nephrology and child health. The doctor has worked at Izmir Tepecik Training and Research Hospital, Ege University Faculty of Medicine, and SSK Bartin Hospital, contributing significantly to these institutions.

    The doctor completed medical education at Ege University Faculty of Medicine, specializing in Child Health and Diseases, and further specialized in Pediatric Nephrology. This comprehensive educational background underpins a strong clinical focus on pediatric nephrology.

  • Read more
Doctor's visit
Price on request

Nail Paksoy

  • 15 years of experience
  • accreditation:
  • Location: Turkey, Istanbul

  • PROFESSIONAL EXPERIENCE

    2011-2012
    Erzurum Koprukoyu State Hospital
    Department: General Medicine

    2012-2017
    Istanbul University Cerrahpaşa Medical Faculty
    Department: Internal Medicine

    06/2017-10/2017
    Istanbul Gaziosmanpasa Taksim Training and Research Hospital
    Department: Internal Medicine

    10/2017-11/2018
    Istanbul University Istanbul Medical Faculty
    Department: Allergy and Immunology Fellowship

    2018/2022
    Istanbul University Oncology Institute
    Department: Medical Oncology Fellowship

    2022-2023
    Tekirdag City Hospital
    Department: Medical Oncology Specialist

    2023-present
    Istanbul Medipol University Medipol Bahcelievler Private Hospital
    Department: Medical Oncology Assoc. Prof.

     

    EDUCATION

    2005-2011
    Medical Education
    Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

    2012-2017
    Internal Medicine
    Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

    2017-2018
    Allergy-Immunology Fellowship
    Istanbul University Istanbul Medical Faculty
    Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

    2018-2022
    Medical Oncology Fellowship
    Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

    2022
    ESMO Board Certification in Medical Oncology
    10th September 2022 in Paris, France.

    2023
    Medical Oncology Assoc. Prof.
    Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

     

    INTERNATIONAL CLINICAL TRIALS:

    1. Astefania - ROCHE

    • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
    • Role: Subinvestigator

    2. PFİZER

    • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
    • Role: Subinvestigator

    3. RECITE - AMGEN

    • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
    • Role: Subinvestigator

    4. NAVIGATE - BAYER

    • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
    • Role: Subinvestigator

    5. RUBY - Tesaro (PRA)

    • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
    • Role: Subinvestigator

    6. ENGOT-ov43/GOG-3036 - MSD

    • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
    • Role: Subinvestigator

    7. ASTRA ZENECA

    • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
    • Role: Subinvestigator

    8. ROSY-O - ASTRA ZENECA

    • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
    • Role: Subinvestigator
    •  

    INTERNATIONAL PUBLICATIONS

    I. Published journal articles indexed by SCI, SSCI, and AHCI

    Weekly Paclitaxel in Classic Kaposi Sarcoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
    • Journal: Medicine, 102(5)

    Carboplatin Desensitization in Ovarian Carcinoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
    • Journal: Medicine, 101(45), e31726

    High-Dose Chemotherapy for Ewing’s Sarcoma

    • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
    • Journal: Medicine, 101(49), e32213

    Multidrug Refractory TFE3(+) Renal Cell Carcinoma

    • Authors: Paksoy, Nail, et al.
    • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

    Crizotinib Efficacy in NSCLC with MET Alterations

    • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
    • Journal: Medicine, 101(50), e32368

    Clinicopathological Features in ALK Mutant NSCLC

    • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
    • Journal: Medicine, 101(34)

    PSMA-Based Tumor Burden in Prostate Cancer

    • Authors: HAS SIMSEK, Duygu, et al.
    • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

    Atezolizumab in Metastatic Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: European Urology Focus, 2021, 7.5: 1061-1066

    Pulmonary Sarcomatoid Carcinoma

    • Authors: FERHATOGLU, Ferhat, et al.
    • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

    Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

    Atezolizumab with Chemotherapy in Small Cell Lung Cancer

    • Authors: GÜRBÜZ, Mustafa, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

    FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

    • Authors: AY, Seval, et al.
    • Journal: Journal of Chemotherapy, 2022, 1-7

    Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

    • Authors: CIL, Ibrahim, et al.
    • Journal: Tumori Journal, 2022, 108.1: 19-25

    Real-Life Efficacy of Osimertinib in Advanced NSCLC

    • Authors: HIZAL, Mutlu, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

    ALK-Positive Cells Percentage and Alectinib Efficacy

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
    • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

    Real-World Data on Alectinib in ALK-Positive NSCLC

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
    • Journal: Future Oncology, 18(23), 2573-2582

    Prognostic Factors in Metastatic RCC with T790M Mutation

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

    • Authors: DEMIR, Semra, et al.
    • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

    Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

    • Authors: ÖZDEMIR, Seçil Kepil, et al.
    • Journal: Allergy, 2019, 74.6: 1187-1190

    Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

    • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
    • Journal: The Oncologist, oyad257

    Subsequent Treatments in Hormone-Positive Breast Cancer Progression

    • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
    • Journal: BMC cancer, 23(1), 192

    Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
    • Journal: Scientific Reports, 13(1), 8779

    Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
    • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

    Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

    • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
    • Journal: European Journal of Breast Health, 19(2), 128

    Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

    • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
    • Journal: Future Oncology, 19(10), 727-736

    Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

    • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
    • Journal: [Not specified]

    Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

    • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
    • Journal: Medicine, 102(39), e35383

    Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

    • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
    • Journal: Medicine, 102(41), e35245

    Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

    Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

    Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

    Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

    Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

    Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

    Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

    Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

    Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

    Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

    Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

    Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

    Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

     

    Thesis:

    Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

    International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

    Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

    • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

    Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

    • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

    Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

    • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

    Efficacy of temozolomide in pretreated patients with metastatic sarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

    • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

    • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

    Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

    • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

    Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

    • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

    Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

    • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

     

     

  • Read more
Doctor's visit
Price on request

Fatih Mert

  • 26 years of experience
  • Location: Turkey, Istanbul
  • Dr Fatih Mert specialises in newborn and childhood vaccination programmes at Büyük Anadolu Hospitals. He focuses on integrating immunisation into broader development monitoring for children with special needs.

    • Trained at the Çukurova University Faculty of Medicine
    • Completed a specialist course in Neonatal Resuscitation
    • Manages growth and development retardation alongside immunisation schedules
    • Attends the National Pediatrics Congress to stay current with vaccination protocols
    • Experienced in pediatric rehabilitation and chronic childhood diseases
  • Read more
Doctor's visit
Price on request

Arda Bozgul

  • 20 years of experience
  • Location: Turkey, İzmir
  • Dr Arda Bozgul specialises in paediatric vaccination and growth monitoring at Medicalpoint International Hospital, ensuring children stay on track with essential immunisation schedules.

    • Provides expert vaccination tracking for babies and adolescents
    • Lead paediatrician for well-child monitoring and healthy development
    • Trained at the prestigious Ege University Faculty of Medicine
    • Member of the Izmir Medical Chamber
    • Expertise in managing paediatric infectious diseases and nutrition
  • Read more
Doctor's visit
Price on request

Asli Aslan

  • 28 years of experience
  • Location: Turkey, İzmir
  • Associate Professor Asli Aslan is a leading paediatrics specialist at Medicalpoint International Hospital who focuses on healthy child tracking and vaccination schedules.

    • Awarded the title of Associate Professor of General Paediatrics after rigorous academic and clinical assessment
    • Specialises in managing infectious diseases and periodic fever in children
    • Previously held a long-term position at Ege University Faculty of Medicine
    • Practised at the Aegean Maternity and Gynecology Education and Research Hospital
    • Focuses on preventive care through rigorous immunisation programmes
  • Read more
Doctor's visit
Price on request

Sevil Bilir

  • 20 years of experience
  • Location: Turkey, Istanbul
  • Associate Professor Sevil Bilir is a highly qualified paediatric specialist who leads immunisation and childcare programmes at Medipol Acibadem District Hospital.

    • Earned her PhD and medical specialty in paediatrics from Istanbul Haydarpaşa Numune Training and Research Hospital
    • Held senior academic positions as an Associate Professor at Abant Izzet Baysal University
    • Managed complex paediatric cases and routine health check-ups across several major private Turkish hospitals
    • Specialises in preventative care and childhood immunisation schedules for international families
  • Read more
Doctor's visit
Price on request

Mehmet Emre Tascilar

  • 36 years of experience
  • Location: Turkey, Ankara
  • Professor Mehmet Emre Tascilar is a highly senior paediatrician who completed a research fellowship at the University of South Florida College of Medicine. He currently leads paediatric services at the JCI-accredited Koru Ankara Hospital.

    • Specialises in managing vaccinations for children with complex endocrine disorders
    • Provides immunisation programmes for patients with diabetes and growth development issues
    • Former flight doctor and specialist at the Gülhane Military Medical Academy
    • Appointed as a full Professor in 2018 at a leading Turkish medical faculty
  • Read more
Doctor's visit
Price on request

Erkan Can

  • 21 years of experience
  • Location: Turkey, Istanbul
  • Education

    Çapa Medical Faculty, Doctor of Medicine Education, 2000, Istanbul/Turkey
    Zeynep Kamil Training and Research Hospital, Pediatrics Education, 2005, Istanbul/Turkey

    Experience

    Zeynep Kamil Training and Research Hospital, 2005, Istanbul/Turkey
    Ankara Gendarmerie Logistics Command, 2007, Ankara/Turkey
    Ankara Mesa Hospital, 2007, Ankara/Turkey
    Medical Park Health Group Bahçelievler Hospital, Istanbul/Turkey

    Medical Intrests

    • Asthma and other allergic diseases
    • Growth retardation and short stature in children

     

    Scientific Memberships

    Istanbul Medical Chamber

  • Read more
Doctor's visit
Price on request

Abdullah Sert

  • 16 years of experience
  • Location: Turkey, Istanbul
  • Education

    Bağcılar Training and Research Hospital, Pediatrics Residency, 2015, Istanbul/Turkey
    Istanbul University Cerrahpaşa Faculty of Medicine, Doctor of Medicine Education, 2010, Istanbul/Turkey.

     

    Experience

    Başakşehir State Hospital, 2016-2018, Istanbul/Turkey
    Bağcılar Training and Research Hospital, 2013-2015, Istanbul/Turkey
    Kocaeli University Faculty of Medicine, 2011-2013, Kocaeli/Turkey
    Kovancılar State Hospital, 2010-2011, Elazığ/Turkey

     

    Medical Intrests

    • Child Allergy
    • Child Infection
    • Child Growth and Development
  • Read more
Doctor's visit
Price on request

Murat Seringec

  • 22 years of experience
  • Location: Turkey, Istanbul
  • Clinic:
    4.1
    Emsey Hospital
  • The doctor specializes in the treatment of child asthma and allergy diseases, pediatric nephrology, and pediatric infectious diseases. With a robust career spanning several reputable medical institutions, the doctor has gained extensive experience in pediatric medicine. The professional journey includes tenures at Pendik Hospital, Emsey Hospital, Hisar Hospital, and Ada Medical Hospital, with a return to Emsey Hospital in 2019, where the doctor continues to practice.

  • Read more
Doctor's visit
Price on request

Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.

Yan Matsiivskiy

Head of Medical Coordinator Team

4300++ patient journeys guided

3 years at Bookimed

278 patients from Turkey have found their doctor through us this month

How you'll get your perfect doctor match

1

2 min Quiz

Tell us your goal, budget, timeline

2

Human Matching + AI

Our algorithm finds matches, coordinator verifies fit

3

Your Options Ready

Compare prices, packages, dates. Chat with your coordinator

Overwhelmed by choices?

Your personal Bookimed coordinator helps you find the perfect surgeon tailored to your needs

  • Supports you 24/7 at every stage
  • Helps match you with the doctor and handles all communication with clinics
  • Coordinates your travel, accommodation, and transfers

Guiding your treatment

Medically trained personal coordinators

Peguy Beaugris
Tetyana Hyrych
Zekra Eldeeb
Victoria Olayinka
Iryna Sydorchuk
Tetiana Ihnatiuk

Choosing the Right Doctor and Clinic: Insider Tips

When selecting a doctor or clinic, keep these key points in mind:
Check credentials
Verify certifications from bodies like ISAPS, JCI, or relevant medical boards
Review success rates
Choose doctors with solid experience and a proven track record in your specific treatment.
Read patient reviews
Browse Bookimed reviews from real patients to learn about their experiences.
Ensure effective communication
Pick clinics that offer language support for a smooth treatment process.
Ask about services
Confirm whether the price includes services such as accommodation, local transfers, and follow-up care to avoid hidden costs.

Bookimed Insights: Top Vaccination Specialists in Turkey for Australians (2026)

Bookimed helps Australian patients find top Vaccination surgeons in Turkey, collaborating with 11 leading specialists. The doctors in this ranking are selected based on their international credentials, clinical expertise, English proficiency, number of performed cases, and patient outcomes. The 2026 ranking is formed using verified data from actual patient cases — including reviews from Australian travellers — and current programmes from our partner clinics. All prices are displayed in AUD for easy comparison with Vaccination costs in Australia.
RankDoctorexperienceGood Fit ForWhat Sets Them ApartClinic & LocationConsultation
#126 years of experienceNewborn and childhood immunisationSpecialises in vaccination schedules for infants and children with special needs. Holds certifications in Neonatal Resuscitation and Mechanical Ventilation from specialised medical courses.
Turkey
Price on request
#220 years of experiencePaediatric immunisation schedulesExpertise in dedicated vaccination tracking and infectious disease prevention for children. Trained at Ege University with a focus on comprehensive well-child monitoring.
Turkey
Price on request
#328 years of experiencePaediatric immunisation and health trackingAs an Associate Professor of General Paediatrics, she combines academic expertise with extensive clinical experience in infectious diseases and child health monitoring.
Turkey
Price on request
#420 years of experiencePaediatric immunisation and preventative careAssociate Professor with a PhD in paediatrics and extensive academic background. She focuses on preventative health and childhood vaccinations within the prestigious Medipol hospital network.
Turkey
Price on request
#536 years of experiencePaediatric immunisation for complex health casesFellowship-trained at the University of South Florida. Expert in tailoring vaccination schedules for children with endocrine conditions like diabetes, obesity, and thyroid disorders to ensure safe preventive care.
Turkey
Price on request

FAQ

These FAQs come from real patients seeking medical assistance through Bookimed. Answers are given by experienced medical coordinators and trusted clinic representatives.

Do vaccination doctors in Turkey speak English?

English proficiency is standard among vaccination specialists at private hospitals in Istanbul and Ankara. Many top doctors hold international fellowships or degrees from prestigious medical schools. Professionals like Prof. Dr. Onder Yavascan are fluent in English and cater specifically to international patients.

  • International training: Professors often complete research fellowships at US institutions like the University of South Florida.
  • Bilingual specialists: Leading pediatricians at Medipol Mega University Hospital officially list English as a spoken language.
  • Dedicated translators: JCI-accredited clinics provide on-site interpreters to assist with registration and medical records.
  • Administrative support: International departments help manage vaccination protocols for patients who prefer English communication.

Bookimed Expert Insight: Data shows that academic pediatricians at university hospitals often have the best language skills. Prof. Dr. Mehmet Emre Tascilar and Prof. Dr. Onder Yavascan both have extensive international backgrounds. Choosing a professor at a private university facility typically ensures clear communication and academic expertise.

Patient Consensus: Patients note that private clinics usually provide translators who guide them through every step. Some mention that while front-desk staff might have limited English, the medical coordinators are very helpful. Most found the coordination through WhatsApp and on-site support made the vaccination process simple.

Do vaccination doctors in Turkey follow international dosing schedules and clinical guidelines?

Vaccination doctors in Turkey adhere to evidence-based clinical guidelines. They primarily follow the National Immunization Schedule set by the Ministry of Health. This system aligns closely with WHO and CDC standards. Top specialists integrate international dosing protocols into their clinical practice for pediatric and adult care.

  • Academic training: Doctors like Dr. Kursad Aydin focus on academic, evidence-based immunization approaches.
  • Global standards: Clinics like Medipol Mega University Hospital maintain JCI-accredited safety and dosing standards.
  • Specialized protocols: Dr. Nail Paksoy follows international ESMO board-certified protocols for cancer vaccination.
  • WHO collaboration: Emsey Hospital follows WHO and UNICEF guidelines through the Baby-friendly Hospital Initiative.

Bookimed Expert Insight: Data shows that university-affiliated physicians in Istanbul and Ankara frequently participate in international clinical trials. For example, Dr. Nail Paksoy has served as a subinvestigator in 8 international trials. These doctors are uniquely positioned to adapt schedules for patients who started their vaccinations in other countries.

Patient Consensus: Patients note that private clinics are predictable for handling international paperwork and specific vaccine manufacturers. Many mention that receiving a clear vaccination card is helpful for keeping records accurate during travel. Experts at these facilities often provide helpful counseling about booster timing for children.

How open are Turkish gynecologists and family physicians to vaccinating pregnant patients?

Turkish gynecologists show extremely high openness to tetanus and diphtheria vaccinations during pregnancy. Most specialists routinely recommend these vaccines to expectant mothers. Openness to influenza and pertussis shots remains moderate. High support exists for pertussis among gynecologists despite low average practice rates.

  • Tetanus integration: Around 98% of Turkish doctors routinely support tetanus and diphtheria vaccination.
  • Specialty divide: Gynecologists report higher willingness to recommend pertussis vaccines than family physicians.
  • Training gaps: Many family doctors seek more data on non-tetanus vaccine safety during pregnancy.
  • Logistic barriers: Vaccination often happens at family health centers rather than in gynecologists clinics.

Bookimed Expert Insight: Turkish gynecologists emphasize that tetanus shots are often already tracked in primary healthcare monitoring systems. Patients may find that specialists like Prof. Dr. Mehmet Emre Tascilar or Dr. Kursad Aydin focus on evidence-based protocols. Choosing university-affiliated hospitals like Medipol Mega often provides better access to updated immunization schedules.

Patient Consensus: Patients note that doctors might not offer vaccines unless they are specifically asked during appointments. Bringing written guidelines helps mothers get much more concrete answers from their medical teams. Many appreciate having translators who help clarify vaccine details in the HES health application.

Which types of doctors in Turkey can administer adult booster shots?

Turkish family physicians primarily manage adult booster shots through the national immunization framework. Specialized care for complex boosters is provided by infectious disease specialists and immunologists like Dr. Nail Paksoy at Medipol Bahçelievler University Hospital. These experts handle vaccination protocols for high-risk patients and those with specific health conditions.

  • Family physicians: Manage routine tetanus-diphtheria and seasonal flu boosters at local centers.
  • Infectious disease specialists: Oversee complex catch-up schedules and travel-related immunization protocols.
  • Medical oncologists: Coordinate specific booster shots for patients undergoing intensive cancer therapies.
  • Specialized pediatricians: Experts like Dr. Kursad Aydin manage preventive care and childhood-to-adult transitions.

Bookimed Expert Insight: Data shows that choosing university hospitals like Medipol Mega or Biruni often provides better access to international vaccination records. Specialists here, such as Dr. Kursad Aydin or Dr. Murat Seringec, emphasize evidence-based protocols that are easily recognized by foreign health authorities. Consultation fees for these specialists typically range from $110 to $130 at leading Istanbul facilities.

Patient Consensus: Patients note that visiting larger private hospitals makes the registration and documentation process much faster. They appreciate when clinics provide translators to help navigate the digital health platforms and HES applications. Many were surprised by how quickly the staff handled both the medical consultation and the physical administration of the shot.

Can foreigners easily schedule a vaccination appointment with public-sector doctors in Turkey?

Foreigners face challenges scheduling public-sector vaccinations in Turkey without a residency permit and Foreigner ID Number. Standard public systems like MHRS require these credentials for elective shots. However, emergency vaccines such as rabies or tetanus are accessible at public state hospitals regardless of status.

  • Residency requirement: Accessing public family health centers requires a valid Turkish Foreigner Residence Permit.
  • Digital credentials: Booking through digital platforms requires a Foreigner ID starting with 99.
  • Language barriers: Public-sector staff and booking hotlines operate primarily in the Turkish language.
  • Private alternatives: International hospitals offer elective vaccinations with English-speaking staff and no ID restrictions.

Bookimed Expert Insight: While public systems are data-dependent, several experienced doctors like Dr. Onder Yavascan are fluent in English and practice at JCI-accredited clinics. Private institutions like Medipol Mega University Hospital provide dedicated translators to handle registration hurdles. This avoids common bureaucratic friction found in state facilities when managing complex immunization schedules.

Patient Consensus: Patients note that navigating the public health system feels more like a paperwork challenge than a medical one. Many say going in person with a local translator works better than using online apps. They emphasize that private clinics provide a much faster experience for routine shots like the Pfizer vaccine.